» Articles » PMID: 29843762

Mechanisms of Electrical Vasoconstriction

Overview
Publisher Biomed Central
Date 2018 May 31
PMID 29843762
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Electrical vasoconstriction is a promising approach to control blood pressure or restrict bleeding in non-compressible wounds. We explore the neural and non-neural pathways of electrical vasoconstriction in-vivo.

Methods: Charge-balanced, asymmetric pulses were delivered through a pair of metal disc electrodes. Vasoconstriction was assessed by measuring the diameter of rat saphenous vessels stimulated with low-voltage (20 V, 1 ms) and high-voltage (150 V, 10 μs) stimuli at 10 Hz for 5 min. Activation pathways were explored by topical application of a specific neural agonist (phenylephrine, alpha-1 receptor), a non-specific agonist (KCl) and neural inhibitors (phenoxybenzamine, 25 mg/ml; guanethidine, 1 mg/ml). Acute tissue damage was assessed with a membrane permeability (live-dead) fluorescent assay. The Joule heating in tissue was estimated using COMSOL Multiphysics modeling.

Results: During stimulation, arteries constricted to 41 ± 8% and 37 ± 6% of their pre-stimulus diameter with low- and high-voltage stimuli, while veins constricted to 80 ± 18% and 40 ± 11%, respectively. In arteries, despite similar extent of constriction, the recovery time was very different: about 30 s for low-voltage and 10 min for high-voltage stimuli. Neural inhibitors significantly reduced low-voltage arterial constriction, but did not affect high-voltage arterial or venous constriction, indicating that high-voltage stimuli activate non-neural vasoconstriction pathways. Adrenergic pathways predominantly controlled low-voltage arterial but not venous constriction, which may involve a purinergic pathway. Viability staining confirmed that stimuli were below the electroporation threshold. Modeling indicates that heating of the blood vessels during stimulation (< 0.2 °C) is too low to cause vasoconstriction.

Conclusions: We demonstrate that low-voltage stimuli induce reversible vasoconstriction through neural pathways, while high-voltage stimuli activate non-neural pathways, likely in addition to neural stimulation. Different stimuli providing precise control over the extent of arterial and venous constriction as well as relaxation rate could be used to control bleeding, perfusion or blood pressure.

Citing Articles

In-silico tool based on Boolean networks and meshless simulations for prediction of reaction and transport mechanisms in the systemic administration of chemotherapeutic drugs.

Velez Salazar F, Patino I PLoS One. 2025; 20(2):e0315194.

PMID: 39919263 PMC: 11805580. DOI: 10.1371/journal.pone.0315194.


Regulation of Cerebral Blood Flow Velocity by Transcutaneous Electrical Nerve Stimulation: A Preliminary Study.

Yang E, Jung J, Kang C Healthcare (Basel). 2024; 12(19).

PMID: 39408088 PMC: 11476227. DOI: 10.3390/healthcare12191908.


Decreasing the blood flow of non-compressible intra-abdominal organs with non-invasive transcutaneous electrical stimulation.

Cakmak Y, Khwaounjoo P, Pangilinan J, Wise I, Burrows C, Kolakshyapati P Sci Rep. 2024; 14(1):10122.

PMID: 38698055 PMC: 11066058. DOI: 10.1038/s41598-024-55165-8.


Future treatment options for facial nerve palsy: a review on electrical stimulation devices for the orbicularis oculi muscle.

Scherrer E, Chaloupka K Neurol Sci. 2023; 45(5):1969-1977.

PMID: 38114854 PMC: 11021255. DOI: 10.1007/s10072-023-07226-5.


Influence of electric field, blood velocity, and pharmacokinetics on electrochemotherapy efficiency.

Velez Salazar F, Patino Arcila I Biophys J. 2023; 122(16):3268-3298.

PMID: 37421133 PMC: 10465711. DOI: 10.1016/j.bpj.2023.07.004.


References
1.
Kur J, Newman E . Purinergic control of vascular tone in the retina. J Physiol. 2013; 592(3):491-504. PMC: 3930435. DOI: 10.1113/jphysiol.2013.267294. View

2.
Ferrell W, Khoshbaten A . Responses of blood vessels in the rabbit knee to electrical stimulation of the joint capsule. J Physiol. 1990; 423:569-78. PMC: 1189775. DOI: 10.1113/jphysiol.1990.sp018040. View

3.
Davis M, Hill M . Signaling mechanisms underlying the vascular myogenic response. Physiol Rev. 1999; 79(2):387-423. DOI: 10.1152/physrev.1999.79.2.387. View

4.
Majumder K, Wu J . Molecular targets of antihypertensive peptides: understanding the mechanisms of action based on the pathophysiology of hypertension. Int J Mol Sci. 2014; 16(1):256-83. PMC: 4307246. DOI: 10.3390/ijms16010256. View

5.
Schubert R, Lidington D, Bolz S . The emerging role of Ca2+ sensitivity regulation in promoting myogenic vasoconstriction. Cardiovasc Res. 2007; 77(1):8-18. DOI: 10.1016/j.cardiores.2007.07.018. View